nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—CYP2D6—breast cancer	0.081	0.389	CbGaD
Quetiapine—CYP3A4—breast cancer	0.0695	0.333	CbGaD
Quetiapine—Promazine—Tamoxifen—breast cancer	0.062	1	CrCrCtD
Quetiapine—ABCB1—breast cancer	0.0579	0.278	CbGaD
Quetiapine—HTR6—Raloxifene—breast cancer	0.0446	0.121	CbGbCtD
Quetiapine—CYP3A5—Lapatinib—breast cancer	0.0167	0.0453	CbGbCtD
Quetiapine—ABCB1—Toremifene—breast cancer	0.0149	0.0404	CbGbCtD
Quetiapine—CYP2C19—Lapatinib—breast cancer	0.0135	0.0365	CbGbCtD
Quetiapine—CYP3A4—Exemestane—breast cancer	0.0129	0.0349	CbGbCtD
Quetiapine—CYP2D6—Idarubicin—breast cancer	0.0117	0.0315	CbGbCtD
Quetiapine—CYP3A7—Tamoxifen—breast cancer	0.0112	0.0302	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.0112	0.0302	CbGbCtD
Quetiapine—CYP3A4—Letrozole—breast cancer	0.011	0.0297	CbGbCtD
Quetiapine—ABCB1—Lapatinib—breast cancer	0.0109	0.0295	CbGbCtD
Quetiapine—CYP3A4—Anastrozole—breast cancer	0.00978	0.0265	CbGbCtD
Quetiapine—CYP3A4—Toremifene—breast cancer	0.00894	0.0242	CbGbCtD
Quetiapine—CYP3A7—Paclitaxel—breast cancer	0.00869	0.0235	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.00869	0.0235	CbGbCtD
Quetiapine—CYP3A7—Irinotecan—breast cancer	0.00858	0.0232	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.00858	0.0232	CbGbCtD
Quetiapine—CYP3A5—Tamoxifen—breast cancer	0.00838	0.0227	CbGbCtD
Quetiapine—CYP3A4—Fulvestrant—breast cancer	0.00831	0.0225	CbGbCtD
Quetiapine—CYP3A4—Thiotepa—breast cancer	0.00741	0.0201	CbGbCtD
Quetiapine—CYP3A4—Ixabepilone—breast cancer	0.00678	0.0183	CbGbCtD
Quetiapine—CYP2C19—Tamoxifen—breast cancer	0.00676	0.0183	CbGbCtD
Quetiapine—CYP3A4—Lapatinib—breast cancer	0.00652	0.0177	CbGbCtD
Quetiapine—CYP3A5—Paclitaxel—breast cancer	0.00652	0.0177	CbGbCtD
Quetiapine—CYP3A5—Irinotecan—breast cancer	0.00643	0.0174	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.00629	0.017	CbGbCtD
Quetiapine—CYP3A7—Docetaxel—breast cancer	0.00629	0.017	CbGbCtD
Quetiapine—ABCB1—Vinorelbine—breast cancer	0.00604	0.0164	CbGbCtD
Quetiapine—CYP2D6—Vinorelbine—breast cancer	0.00569	0.0154	CbGbCtD
Quetiapine—ABCB1—Tamoxifen—breast cancer	0.00545	0.0148	CbGbCtD
Quetiapine—ABCB1—Mitoxantrone—breast cancer	0.00532	0.0144	CbGbCtD
Quetiapine—CYP2D6—Tamoxifen—breast cancer	0.00514	0.0139	CbGbCtD
Quetiapine—CYP3A4—Raloxifene—breast cancer	0.00494	0.0134	CbGbCtD
Quetiapine—CYP3A5—Docetaxel—breast cancer	0.00471	0.0128	CbGbCtD
Quetiapine—ABCB1—Gemcitabine—breast cancer	0.0047	0.0127	CbGbCtD
Quetiapine—ABCB1—Paclitaxel—breast cancer	0.00424	0.0115	CbGbCtD
Quetiapine—ABCB1—Irinotecan—breast cancer	0.00419	0.0113	CbGbCtD
Quetiapine—ABCB1—Vinblastine—breast cancer	0.00372	0.0101	CbGbCtD
Quetiapine—CYP3A4—Vinorelbine—breast cancer	0.00362	0.0098	CbGbCtD
Quetiapine—CYP2D6—Vinblastine—breast cancer	0.00351	0.00949	CbGbCtD
Quetiapine—CYP3A4—Tamoxifen—breast cancer	0.00327	0.00884	CbGbCtD
Quetiapine—CYP3A4—Mitoxantrone—breast cancer	0.00319	0.00862	CbGbCtD
Quetiapine—ABCB1—Docetaxel—breast cancer	0.00307	0.00831	CbGbCtD
Quetiapine—CHRM3—muscle of abdomen—breast cancer	0.00284	0.0966	CbGeAlD
Quetiapine—CYP3A4—Paclitaxel—breast cancer	0.00254	0.00688	CbGbCtD
Quetiapine—CYP3A4—Irinotecan—breast cancer	0.00251	0.00679	CbGbCtD
Quetiapine—ABCB1—Doxorubicin—breast cancer	0.00229	0.00619	CbGbCtD
Quetiapine—CYP3A4—Vinblastine—breast cancer	0.00223	0.00604	CbGbCtD
Quetiapine—ABCB1—Methotrexate—breast cancer	0.00222	0.006	CbGbCtD
Quetiapine—CYP2D6—Doxorubicin—breast cancer	0.00216	0.00583	CbGbCtD
Quetiapine—CYP3A4—Docetaxel—breast cancer	0.00184	0.00498	CbGbCtD
Quetiapine—CYP3A4—Doxorubicin—breast cancer	0.00137	0.00371	CbGbCtD
Quetiapine—H1F0—mammary gland—breast cancer	0.000937	0.0318	CbGeAlD
Quetiapine—H1F0—nipple—breast cancer	0.000775	0.0263	CbGeAlD
Quetiapine—Trifluoperazine—S100A4—breast cancer	0.000691	0.245	CrCbGaD
Quetiapine—H1F0—embryo—breast cancer	0.000639	0.0217	CbGeAlD
Quetiapine—CHRM5—epithelium—breast cancer	0.000605	0.0206	CbGeAlD
Quetiapine—HTR1E—female gonad—breast cancer	0.000597	0.0203	CbGeAlD
Quetiapine—CHRM5—skin of body—breast cancer	0.000575	0.0196	CbGeAlD
Quetiapine—ADRA1D—epithelium—breast cancer	0.000541	0.0184	CbGeAlD
Quetiapine—DRD5—female reproductive system—breast cancer	0.000501	0.017	CbGeAlD
Quetiapine—H1F0—skin of body—breast cancer	0.000496	0.0169	CbGeAlD
Quetiapine—H1F0—endometrium—breast cancer	0.000468	0.0159	CbGeAlD
Quetiapine—DRD5—female gonad—breast cancer	0.000456	0.0155	CbGeAlD
Quetiapine—CYP3A7—endocrine gland—breast cancer	0.000442	0.015	CbGeAlD
Quetiapine—ADRA2C—nipple—breast cancer	0.000439	0.0149	CbGeAlD
Quetiapine—H1F0—uterus—breast cancer	0.000431	0.0147	CbGeAlD
Quetiapine—DRD5—endocrine gland—breast cancer	0.000424	0.0144	CbGeAlD
Quetiapine—H1F0—pituitary gland—breast cancer	0.000423	0.0144	CbGeAlD
Quetiapine—H1F0—adipose tissue—breast cancer	0.000422	0.0143	CbGeAlD
Quetiapine—ADRA1D—female reproductive system—breast cancer	0.000402	0.0137	CbGeAlD
Quetiapine—H1F0—female reproductive system—breast cancer	0.000388	0.0132	CbGeAlD
Quetiapine—H1F0—adrenal gland—breast cancer	0.000378	0.0129	CbGeAlD
Quetiapine—H1F0—bone marrow—breast cancer	0.000366	0.0124	CbGeAlD
Quetiapine—HRH1—nipple—breast cancer	0.000357	0.0121	CbGeAlD
Quetiapine—H1F0—female gonad—breast cancer	0.000353	0.012	CbGeAlD
Quetiapine—ADRA2A—nipple—breast cancer	0.000351	0.0119	CbGeAlD
Quetiapine—ADRA1D—endocrine gland—breast cancer	0.00034	0.0116	CbGeAlD
Quetiapine—H1F0—endocrine gland—breast cancer	0.000328	0.0111	CbGeAlD
Quetiapine—HTR7—epithelium—breast cancer	0.000322	0.0109	CbGeAlD
Quetiapine—ADRA1A—epithelium—breast cancer	0.000311	0.0106	CbGeAlD
Quetiapine—HTR1B—female reproductive system—breast cancer	0.00031	0.0105	CbGeAlD
Quetiapine—HTR1D—female reproductive system—breast cancer	0.0003	0.0102	CbGeAlD
Quetiapine—HTR2C—female reproductive system—breast cancer	0.000297	0.0101	CbGeAlD
Quetiapine—CHRM1—female reproductive system—breast cancer	0.000281	0.00954	CbGeAlD
Quetiapine—CHRM3—adipose tissue—breast cancer	0.000273	0.00929	CbGeAlD
Quetiapine—ADRA2C—endometrium—breast cancer	0.000265	0.00902	CbGeAlD
Quetiapine—HTR1B—endocrine gland—breast cancer	0.000262	0.00892	CbGeAlD
Quetiapine—CHRM2—endocrine gland—breast cancer	0.000261	0.00887	CbGeAlD
Quetiapine—CHRM3—female reproductive system—breast cancer	0.000251	0.00854	CbGeAlD
Quetiapine—ADRA1A—adipose tissue—breast cancer	0.000251	0.00853	CbGeAlD
Quetiapine—DRD2—pituitary gland—breast cancer	0.000247	0.0084	CbGeAlD
Quetiapine—HTR2A—embryo—breast cancer	0.000246	0.00836	CbGeAlD
Quetiapine—ADRA2C—uterus—breast cancer	0.000244	0.00831	CbGeAlD
Quetiapine—HTR1A—adrenal gland—breast cancer	0.000244	0.0083	CbGeAlD
Quetiapine—HRH1—epithelium—breast cancer	0.00024	0.00817	CbGeAlD
Quetiapine—ADRA2C—pituitary gland—breast cancer	0.00024	0.00816	CbGeAlD
Quetiapine—HTR7—female reproductive system—breast cancer	0.000239	0.00813	CbGeAlD
Quetiapine—ADRA2C—adipose tissue—breast cancer	0.000239	0.00813	CbGeAlD
Quetiapine—CHRM1—endocrine gland—breast cancer	0.000238	0.00808	CbGeAlD
Quetiapine—HTR7—adrenal gland—breast cancer	0.000233	0.00793	CbGeAlD
Quetiapine—CHRM3—female gonad—breast cancer	0.000229	0.00777	CbGeAlD
Quetiapine—H1F0—lymph node—breast cancer	0.000227	0.00771	CbGeAlD
Quetiapine—ADRA1A—adrenal gland—breast cancer	0.000225	0.00765	CbGeAlD
Quetiapine—HRH1—endometrium—breast cancer	0.000216	0.00733	CbGeAlD
Quetiapine—ADRA2C—adrenal gland—breast cancer	0.000214	0.00729	CbGeAlD
Quetiapine—CHRM3—endocrine gland—breast cancer	0.000213	0.00723	CbGeAlD
Quetiapine—HTR1A—endocrine gland—breast cancer	0.000212	0.0072	CbGeAlD
Quetiapine—ADRA2A—endometrium—breast cancer	0.000212	0.0072	CbGeAlD
Quetiapine—HTR7—endocrine gland—breast cancer	0.000202	0.00688	CbGeAlD
Quetiapine—HTR2A—epithelium—breast cancer	0.000201	0.00682	CbGeAlD
Quetiapine—CYP3A5—adipose tissue—breast cancer	0.0002	0.0068	CbGeAlD
Quetiapine—ADRA2C—female gonad—breast cancer	0.0002	0.0068	CbGeAlD
Quetiapine—CYP2C19—endocrine gland—breast cancer	0.000198	0.00672	CbGeAlD
Quetiapine—ADRA1A—endocrine gland—breast cancer	0.000195	0.00664	CbGeAlD
Quetiapine—ADRA2A—uterus—breast cancer	0.000195	0.00663	CbGeAlD
Quetiapine—HRH1—adipose tissue—breast cancer	0.000194	0.0066	CbGeAlD
Quetiapine—ADRA2A—pituitary gland—breast cancer	0.000192	0.00651	CbGeAlD
Quetiapine—DRD2—endocrine gland—breast cancer	0.000191	0.0065	CbGeAlD
Quetiapine—ADRA2A—adipose tissue—breast cancer	0.000191	0.00649	CbGeAlD
Quetiapine—HRH1—female reproductive system—breast cancer	0.000179	0.00607	CbGeAlD
Quetiapine—ADRA2A—female reproductive system—breast cancer	0.000175	0.00596	CbGeAlD
Quetiapine—HRH1—adrenal gland—breast cancer	0.000174	0.00592	CbGeAlD
Quetiapine—ADRA2A—adrenal gland—breast cancer	0.000171	0.00582	CbGeAlD
Quetiapine—CYP3A5—female gonad—breast cancer	0.000167	0.00569	CbGeAlD
Quetiapine—HTR2A—pituitary gland—breast cancer	0.000163	0.00554	CbGeAlD
Quetiapine—HRH1—female gonad—breast cancer	0.000162	0.00552	CbGeAlD
Quetiapine—ABCB1—embryo—breast cancer	0.000161	0.00548	CbGeAlD
Quetiapine—ADRA2A—female gonad—breast cancer	0.00016	0.00543	CbGeAlD
Quetiapine—CYP3A5—endocrine gland—breast cancer	0.000156	0.00529	CbGeAlD
Quetiapine—HRH1—endocrine gland—breast cancer	0.000151	0.00514	CbGeAlD
Quetiapine—HTR2A—female reproductive system—breast cancer	0.000149	0.00507	CbGeAlD
Quetiapine—ADRA2A—endocrine gland—breast cancer	0.000148	0.00505	CbGeAlD
Quetiapine—HTR2A—adrenal gland—breast cancer	0.000146	0.00495	CbGeAlD
Quetiapine—Hydroxyzine—CYP2D6—breast cancer	0.000143	0.0508	CrCbGaD
Quetiapine—CYP3A4—female reproductive system—breast cancer	0.000138	0.00469	CbGeAlD
Quetiapine—CYP2D6—female reproductive system—breast cancer	0.000136	0.00462	CbGeAlD
Quetiapine—ABCB1—epithelium—breast cancer	0.000132	0.00447	CbGeAlD
Quetiapine—ADRA2C—lymph node—breast cancer	0.000129	0.00437	CbGeAlD
Quetiapine—HTR2A—endocrine gland—breast cancer	0.000126	0.00429	CbGeAlD
Quetiapine—CYP2D6—female gonad—breast cancer	0.000124	0.0042	CbGeAlD
Quetiapine—ABCB1—endometrium—breast cancer	0.000118	0.00401	CbGeAlD
Quetiapine—CYP3A4—endocrine gland—breast cancer	0.000117	0.00397	CbGeAlD
Quetiapine—CYP2D6—endocrine gland—breast cancer	0.000115	0.00391	CbGeAlD
Quetiapine—ABCB1—uterus—breast cancer	0.000109	0.0037	CbGeAlD
Quetiapine—ABCB1—pituitary gland—breast cancer	0.000107	0.00363	CbGeAlD
Quetiapine—ABCB1—adipose tissue—breast cancer	0.000106	0.00361	CbGeAlD
Quetiapine—HRH1—lymph node—breast cancer	0.000104	0.00355	CbGeAlD
Quetiapine—ADRA2A—lymph node—breast cancer	0.000103	0.00349	CbGeAlD
Quetiapine—Flupentixol—ABCB1—breast cancer	9.79e-05	0.0348	CrCbGaD
Quetiapine—ABCB1—female reproductive system—breast cancer	9.77e-05	0.00332	CbGeAlD
Quetiapine—ABCB1—adrenal gland—breast cancer	9.54e-05	0.00324	CbGeAlD
Quetiapine—Clozapine—CYP1B1—breast cancer	9.53e-05	0.0338	CrCbGaD
Quetiapine—Mequitazine—CYP2D6—breast cancer	9.34e-05	0.0331	CrCbGaD
Quetiapine—ABCB1—bone marrow—breast cancer	9.23e-05	0.00314	CbGeAlD
Quetiapine—ABCB1—female gonad—breast cancer	8.89e-05	0.00302	CbGeAlD
Quetiapine—ABCB1—endocrine gland—breast cancer	8.27e-05	0.00281	CbGeAlD
Quetiapine—Mequitazine—CYP3A4—breast cancer	8.01e-05	0.0284	CrCbGaD
Quetiapine—Zuclopenthixol—CYP2D6—breast cancer	7.71e-05	0.0273	CrCbGaD
Quetiapine—Nefazodone—CYP2D6—breast cancer	7.66e-05	0.0272	CrCbGaD
Quetiapine—Olanzapine—CYP2D6—breast cancer	7.34e-05	0.026	CrCbGaD
Quetiapine—Trazodone—CYP2D6—breast cancer	7.09e-05	0.0252	CrCbGaD
Quetiapine—Thiothixene—CYP2D6—breast cancer	6.64e-05	0.0236	CrCbGaD
Quetiapine—Pipotiazine—CYP2D6—breast cancer	6.64e-05	0.0236	CrCbGaD
Quetiapine—Nefazodone—CYP3A4—breast cancer	6.57e-05	0.0233	CrCbGaD
Quetiapine—Prochlorperazine—CYP2D6—breast cancer	6.35e-05	0.0225	CrCbGaD
Quetiapine—Olanzapine—CYP3A4—breast cancer	6.29e-05	0.0223	CrCbGaD
Quetiapine—Trazodone—CYP3A4—breast cancer	6.08e-05	0.0216	CrCbGaD
Quetiapine—Amoxapine—CYP2D6—breast cancer	5.84e-05	0.0207	CrCbGaD
Quetiapine—Fluphenazine—CYP2D6—breast cancer	5.74e-05	0.0204	CrCbGaD
Quetiapine—ABCB1—lymph node—breast cancer	5.72e-05	0.00194	CbGeAlD
Quetiapine—Pipotiazine—CYP3A4—breast cancer	5.7e-05	0.0202	CrCbGaD
Quetiapine—Olanzapine—ALB—breast cancer	5.49e-05	0.0195	CrCbGaD
Quetiapine—Nefazodone—ABCB1—breast cancer	5.47e-05	0.0194	CrCbGaD
Quetiapine—Prochlorperazine—CYP3A4—breast cancer	5.45e-05	0.0193	CrCbGaD
Quetiapine—Olanzapine—ABCB1—breast cancer	5.24e-05	0.0186	CrCbGaD
Quetiapine—Clozapine—CYP1A1—breast cancer	5.15e-05	0.0183	CrCbGaD
Quetiapine—Trazodone—ABCB1—breast cancer	5.06e-05	0.018	CrCbGaD
Quetiapine—Thioproperazine—ALB—breast cancer	5.05e-05	0.0179	CrCbGaD
Quetiapine—Pipotiazine—ALB—breast cancer	4.97e-05	0.0176	CrCbGaD
Quetiapine—Thiothixene—ALB—breast cancer	4.97e-05	0.0176	CrCbGaD
Quetiapine—Perphenazine—CYP2D6—breast cancer	4.54e-05	0.0161	CrCbGaD
Quetiapine—Fluphenazine—ABCB1—breast cancer	4.1e-05	0.0145	CrCbGaD
Quetiapine—Perphenazine—CYP3A4—breast cancer	3.89e-05	0.0138	CrCbGaD
Quetiapine—Clozapine—CYP2D6—breast cancer	3.83e-05	0.0136	CrCbGaD
Quetiapine—Promazine—CYP3A4—breast cancer	3.51e-05	0.0125	CrCbGaD
Quetiapine—Clozapine—CYP3A4—breast cancer	3.29e-05	0.0117	CrCbGaD
Quetiapine—Trifluoperazine—ABCB1—breast cancer	3.28e-05	0.0116	CrCbGaD
Quetiapine—Clozapine—ABCB1—breast cancer	2.73e-05	0.0097	CrCbGaD
Quetiapine—Pharyngitis—Doxorubicin—breast cancer	2.12e-05	9.84e-05	CcSEcCtD
Quetiapine—Paraesthesia—Capecitabine—breast cancer	2.11e-05	9.81e-05	CcSEcCtD
Quetiapine—Decreased appetite—Docetaxel—breast cancer	2.11e-05	9.81e-05	CcSEcCtD
Quetiapine—Hypersensitivity—Paclitaxel—breast cancer	2.11e-05	9.81e-05	CcSEcCtD
Quetiapine—Headache—Fluorouracil—breast cancer	2.11e-05	9.8e-05	CcSEcCtD
Quetiapine—Urinary tract disorder—Doxorubicin—breast cancer	2.11e-05	9.79e-05	CcSEcCtD
Quetiapine—Oedema peripheral—Doxorubicin—breast cancer	2.1e-05	9.77e-05	CcSEcCtD
Quetiapine—Dysgeusia—Methotrexate—breast cancer	2.1e-05	9.76e-05	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Docetaxel—breast cancer	2.1e-05	9.75e-05	CcSEcCtD
Quetiapine—Connective tissue disorder—Doxorubicin—breast cancer	2.1e-05	9.74e-05	CcSEcCtD
Quetiapine—Dyspnoea—Capecitabine—breast cancer	2.1e-05	9.74e-05	CcSEcCtD
Quetiapine—Fatigue—Docetaxel—breast cancer	2.09e-05	9.73e-05	CcSEcCtD
Quetiapine—Angiopathy—Epirubicin—breast cancer	2.09e-05	9.72e-05	CcSEcCtD
Quetiapine—Urethral disorder—Doxorubicin—breast cancer	2.09e-05	9.72e-05	CcSEcCtD
Quetiapine—Nausea—Mitoxantrone—breast cancer	2.09e-05	9.7e-05	CcSEcCtD
Quetiapine—Nausea—Irinotecan—breast cancer	2.09e-05	9.7e-05	CcSEcCtD
Quetiapine—Immune system disorder—Epirubicin—breast cancer	2.08e-05	9.68e-05	CcSEcCtD
Quetiapine—Mediastinal disorder—Epirubicin—breast cancer	2.08e-05	9.66e-05	CcSEcCtD
Quetiapine—Pain—Docetaxel—breast cancer	2.08e-05	9.65e-05	CcSEcCtD
Quetiapine—Constipation—Docetaxel—breast cancer	2.08e-05	9.65e-05	CcSEcCtD
Quetiapine—Back pain—Methotrexate—breast cancer	2.07e-05	9.64e-05	CcSEcCtD
Quetiapine—Dyspepsia—Capecitabine—breast cancer	2.07e-05	9.62e-05	CcSEcCtD
Quetiapine—Chills—Epirubicin—breast cancer	2.07e-05	9.62e-05	CcSEcCtD
Quetiapine—Visual impairment—Doxorubicin—breast cancer	2.06e-05	9.56e-05	CcSEcCtD
Quetiapine—Asthenia—Paclitaxel—breast cancer	2.06e-05	9.56e-05	CcSEcCtD
Quetiapine—Decreased appetite—Capecitabine—breast cancer	2.04e-05	9.5e-05	CcSEcCtD
Quetiapine—Nausea—Gemcitabine—breast cancer	2.03e-05	9.45e-05	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Capecitabine—breast cancer	2.03e-05	9.44e-05	CcSEcCtD
Quetiapine—Fatigue—Capecitabine—breast cancer	2.03e-05	9.42e-05	CcSEcCtD
Quetiapine—Pruritus—Paclitaxel—breast cancer	2.03e-05	9.42e-05	CcSEcCtD
Quetiapine—Vision blurred—Methotrexate—breast cancer	2.02e-05	9.39e-05	CcSEcCtD
Quetiapine—Mental disorder—Epirubicin—breast cancer	2.02e-05	9.39e-05	CcSEcCtD
Quetiapine—Erythema multiforme—Doxorubicin—breast cancer	2.02e-05	9.38e-05	CcSEcCtD
Quetiapine—Constipation—Capecitabine—breast cancer	2.01e-05	9.35e-05	CcSEcCtD
Quetiapine—Pain—Capecitabine—breast cancer	2.01e-05	9.35e-05	CcSEcCtD
Quetiapine—Malnutrition—Epirubicin—breast cancer	2.01e-05	9.33e-05	CcSEcCtD
Quetiapine—Feeling abnormal—Docetaxel—breast cancer	2e-05	9.3e-05	CcSEcCtD
Quetiapine—Nausea—Fluorouracil—breast cancer	2e-05	9.29e-05	CcSEcCtD
Quetiapine—Eye disorder—Doxorubicin—breast cancer	1.99e-05	9.27e-05	CcSEcCtD
Quetiapine—Ill-defined disorder—Methotrexate—breast cancer	1.99e-05	9.25e-05	CcSEcCtD
Quetiapine—Tinnitus—Doxorubicin—breast cancer	1.99e-05	9.25e-05	CcSEcCtD
Quetiapine—Gastrointestinal pain—Docetaxel—breast cancer	1.99e-05	9.23e-05	CcSEcCtD
Quetiapine—Anaemia—Methotrexate—breast cancer	1.98e-05	9.21e-05	CcSEcCtD
Quetiapine—Cardiac disorder—Doxorubicin—breast cancer	1.98e-05	9.2e-05	CcSEcCtD
Quetiapine—Flatulence—Epirubicin—breast cancer	1.98e-05	9.19e-05	CcSEcCtD
Quetiapine—Tension—Epirubicin—breast cancer	1.97e-05	9.15e-05	CcSEcCtD
Quetiapine—Dysgeusia—Epirubicin—breast cancer	1.97e-05	9.14e-05	CcSEcCtD
Quetiapine—Diarrhoea—Paclitaxel—breast cancer	1.96e-05	9.11e-05	CcSEcCtD
Quetiapine—Nervousness—Epirubicin—breast cancer	1.95e-05	9.06e-05	CcSEcCtD
Quetiapine—Back pain—Epirubicin—breast cancer	1.94e-05	9.02e-05	CcSEcCtD
Quetiapine—Feeling abnormal—Capecitabine—breast cancer	1.94e-05	9.01e-05	CcSEcCtD
Quetiapine—Angiopathy—Doxorubicin—breast cancer	1.94e-05	9e-05	CcSEcCtD
Quetiapine—Malaise—Methotrexate—breast cancer	1.93e-05	8.99e-05	CcSEcCtD
Quetiapine—Muscle spasms—Epirubicin—breast cancer	1.93e-05	8.97e-05	CcSEcCtD
Quetiapine—Immune system disorder—Doxorubicin—breast cancer	1.93e-05	8.96e-05	CcSEcCtD
Quetiapine—Vertigo—Methotrexate—breast cancer	1.93e-05	8.96e-05	CcSEcCtD
Quetiapine—Gastrointestinal pain—Capecitabine—breast cancer	1.92e-05	8.94e-05	CcSEcCtD
Quetiapine—Mediastinal disorder—Doxorubicin—breast cancer	1.92e-05	8.94e-05	CcSEcCtD
Quetiapine—Abdominal pain—Docetaxel—breast cancer	1.92e-05	8.92e-05	CcSEcCtD
Quetiapine—Body temperature increased—Docetaxel—breast cancer	1.92e-05	8.92e-05	CcSEcCtD
Quetiapine—Leukopenia—Methotrexate—breast cancer	1.92e-05	8.92e-05	CcSEcCtD
Quetiapine—Chills—Doxorubicin—breast cancer	1.91e-05	8.9e-05	CcSEcCtD
Quetiapine—Dizziness—Paclitaxel—breast cancer	1.89e-05	8.81e-05	CcSEcCtD
Quetiapine—Vision blurred—Epirubicin—breast cancer	1.89e-05	8.79e-05	CcSEcCtD
Quetiapine—Cough—Methotrexate—breast cancer	1.87e-05	8.7e-05	CcSEcCtD
Quetiapine—Mental disorder—Doxorubicin—breast cancer	1.87e-05	8.69e-05	CcSEcCtD
Quetiapine—Ill-defined disorder—Epirubicin—breast cancer	1.86e-05	8.66e-05	CcSEcCtD
Quetiapine—Body temperature increased—Capecitabine—breast cancer	1.86e-05	8.64e-05	CcSEcCtD
Quetiapine—Abdominal pain—Capecitabine—breast cancer	1.86e-05	8.64e-05	CcSEcCtD
Quetiapine—Convulsion—Methotrexate—breast cancer	1.86e-05	8.64e-05	CcSEcCtD
Quetiapine—Malnutrition—Doxorubicin—breast cancer	1.86e-05	8.63e-05	CcSEcCtD
Quetiapine—Anaemia—Epirubicin—breast cancer	1.85e-05	8.62e-05	CcSEcCtD
Quetiapine—Agitation—Epirubicin—breast cancer	1.84e-05	8.57e-05	CcSEcCtD
Quetiapine—Flatulence—Doxorubicin—breast cancer	1.83e-05	8.51e-05	CcSEcCtD
Quetiapine—Chest pain—Methotrexate—breast cancer	1.83e-05	8.49e-05	CcSEcCtD
Quetiapine—Myalgia—Methotrexate—breast cancer	1.83e-05	8.49e-05	CcSEcCtD
Quetiapine—Arthralgia—Methotrexate—breast cancer	1.83e-05	8.49e-05	CcSEcCtD
Quetiapine—Tension—Doxorubicin—breast cancer	1.82e-05	8.47e-05	CcSEcCtD
Quetiapine—Vomiting—Paclitaxel—breast cancer	1.82e-05	8.47e-05	CcSEcCtD
Quetiapine—Dysgeusia—Doxorubicin—breast cancer	1.82e-05	8.45e-05	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.81e-05	8.43e-05	CcSEcCtD
Quetiapine—Malaise—Epirubicin—breast cancer	1.81e-05	8.41e-05	CcSEcCtD
Quetiapine—Rash—Paclitaxel—breast cancer	1.81e-05	8.4e-05	CcSEcCtD
Quetiapine—Dermatitis—Paclitaxel—breast cancer	1.8e-05	8.39e-05	CcSEcCtD
Quetiapine—Discomfort—Methotrexate—breast cancer	1.8e-05	8.39e-05	CcSEcCtD
Quetiapine—Nervousness—Doxorubicin—breast cancer	1.8e-05	8.38e-05	CcSEcCtD
Quetiapine—Vertigo—Epirubicin—breast cancer	1.8e-05	8.38e-05	CcSEcCtD
Quetiapine—Syncope—Epirubicin—breast cancer	1.8e-05	8.37e-05	CcSEcCtD
Quetiapine—Leukopenia—Epirubicin—breast cancer	1.8e-05	8.35e-05	CcSEcCtD
Quetiapine—Back pain—Doxorubicin—breast cancer	1.8e-05	8.35e-05	CcSEcCtD
Quetiapine—Headache—Paclitaxel—breast cancer	1.79e-05	8.34e-05	CcSEcCtD
Quetiapine—Hypersensitivity—Docetaxel—breast cancer	1.79e-05	8.32e-05	CcSEcCtD
Quetiapine—Muscle spasms—Doxorubicin—breast cancer	1.79e-05	8.3e-05	CcSEcCtD
Quetiapine—Palpitations—Epirubicin—breast cancer	1.77e-05	8.24e-05	CcSEcCtD
Quetiapine—Confusional state—Methotrexate—breast cancer	1.76e-05	8.2e-05	CcSEcCtD
Quetiapine—Loss of consciousness—Epirubicin—breast cancer	1.76e-05	8.2e-05	CcSEcCtD
Quetiapine—Cough—Epirubicin—breast cancer	1.75e-05	8.14e-05	CcSEcCtD
Quetiapine—Anaphylactic shock—Methotrexate—breast cancer	1.75e-05	8.14e-05	CcSEcCtD
Quetiapine—Vision blurred—Doxorubicin—breast cancer	1.75e-05	8.13e-05	CcSEcCtD
Quetiapine—Asthenia—Docetaxel—breast cancer	1.74e-05	8.1e-05	CcSEcCtD
Quetiapine—Convulsion—Epirubicin—breast cancer	1.74e-05	8.08e-05	CcSEcCtD
Quetiapine—Infection—Methotrexate—breast cancer	1.74e-05	8.08e-05	CcSEcCtD
Quetiapine—Hypertension—Epirubicin—breast cancer	1.73e-05	8.05e-05	CcSEcCtD
Quetiapine—Hypersensitivity—Capecitabine—breast cancer	1.73e-05	8.05e-05	CcSEcCtD
Quetiapine—Ill-defined disorder—Doxorubicin—breast cancer	1.72e-05	8.01e-05	CcSEcCtD
Quetiapine—Pruritus—Docetaxel—breast cancer	1.72e-05	7.99e-05	CcSEcCtD
Quetiapine—Nervous system disorder—Methotrexate—breast cancer	1.72e-05	7.98e-05	CcSEcCtD
Quetiapine—Anaemia—Doxorubicin—breast cancer	1.72e-05	7.98e-05	CcSEcCtD
Quetiapine—Thrombocytopenia—Methotrexate—breast cancer	1.71e-05	7.97e-05	CcSEcCtD
Quetiapine—Myalgia—Epirubicin—breast cancer	1.71e-05	7.94e-05	CcSEcCtD
Quetiapine—Chest pain—Epirubicin—breast cancer	1.71e-05	7.94e-05	CcSEcCtD
Quetiapine—Arthralgia—Epirubicin—breast cancer	1.71e-05	7.94e-05	CcSEcCtD
Quetiapine—Agitation—Doxorubicin—breast cancer	1.71e-05	7.93e-05	CcSEcCtD
Quetiapine—Anxiety—Epirubicin—breast cancer	1.7e-05	7.91e-05	CcSEcCtD
Quetiapine—Nausea—Paclitaxel—breast cancer	1.7e-05	7.91e-05	CcSEcCtD
Quetiapine—Skin disorder—Methotrexate—breast cancer	1.7e-05	7.9e-05	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.7e-05	7.89e-05	CcSEcCtD
Quetiapine—Hyperhidrosis—Methotrexate—breast cancer	1.69e-05	7.87e-05	CcSEcCtD
Quetiapine—Discomfort—Epirubicin—breast cancer	1.69e-05	7.85e-05	CcSEcCtD
Quetiapine—Asthenia—Capecitabine—breast cancer	1.69e-05	7.84e-05	CcSEcCtD
Quetiapine—Malaise—Doxorubicin—breast cancer	1.67e-05	7.78e-05	CcSEcCtD
Quetiapine—Dry mouth—Epirubicin—breast cancer	1.67e-05	7.77e-05	CcSEcCtD
Quetiapine—Vertigo—Doxorubicin—breast cancer	1.67e-05	7.76e-05	CcSEcCtD
Quetiapine—Anorexia—Methotrexate—breast cancer	1.67e-05	7.76e-05	CcSEcCtD
Quetiapine—Syncope—Doxorubicin—breast cancer	1.67e-05	7.74e-05	CcSEcCtD
Quetiapine—Pruritus—Capecitabine—breast cancer	1.66e-05	7.73e-05	CcSEcCtD
Quetiapine—Leukopenia—Doxorubicin—breast cancer	1.66e-05	7.73e-05	CcSEcCtD
Quetiapine—Diarrhoea—Docetaxel—breast cancer	1.66e-05	7.72e-05	CcSEcCtD
Quetiapine—Confusional state—Epirubicin—breast cancer	1.65e-05	7.68e-05	CcSEcCtD
Quetiapine—Palpitations—Doxorubicin—breast cancer	1.64e-05	7.63e-05	CcSEcCtD
Quetiapine—Anaphylactic shock—Epirubicin—breast cancer	1.64e-05	7.61e-05	CcSEcCtD
Quetiapine—Hypotension—Methotrexate—breast cancer	1.64e-05	7.6e-05	CcSEcCtD
Quetiapine—Loss of consciousness—Doxorubicin—breast cancer	1.63e-05	7.59e-05	CcSEcCtD
Quetiapine—Infection—Epirubicin—breast cancer	1.63e-05	7.56e-05	CcSEcCtD
Quetiapine—Cough—Doxorubicin—breast cancer	1.62e-05	7.53e-05	CcSEcCtD
Quetiapine—Shock—Epirubicin—breast cancer	1.61e-05	7.49e-05	CcSEcCtD
Quetiapine—Convulsion—Doxorubicin—breast cancer	1.61e-05	7.48e-05	CcSEcCtD
Quetiapine—Diarrhoea—Capecitabine—breast cancer	1.61e-05	7.48e-05	CcSEcCtD
Quetiapine—Nervous system disorder—Epirubicin—breast cancer	1.61e-05	7.47e-05	CcSEcCtD
Quetiapine—Dizziness—Docetaxel—breast cancer	1.61e-05	7.46e-05	CcSEcCtD
Quetiapine—Thrombocytopenia—Epirubicin—breast cancer	1.6e-05	7.45e-05	CcSEcCtD
Quetiapine—Hypertension—Doxorubicin—breast cancer	1.6e-05	7.45e-05	CcSEcCtD
Quetiapine—Tachycardia—Epirubicin—breast cancer	1.6e-05	7.43e-05	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Methotrexate—breast cancer	1.59e-05	7.41e-05	CcSEcCtD
Quetiapine—Skin disorder—Epirubicin—breast cancer	1.59e-05	7.4e-05	CcSEcCtD
Quetiapine—Hyperhidrosis—Epirubicin—breast cancer	1.58e-05	7.36e-05	CcSEcCtD
Quetiapine—Insomnia—Methotrexate—breast cancer	1.58e-05	7.36e-05	CcSEcCtD
Quetiapine—Chest pain—Doxorubicin—breast cancer	1.58e-05	7.35e-05	CcSEcCtD
Quetiapine—Arthralgia—Doxorubicin—breast cancer	1.58e-05	7.35e-05	CcSEcCtD
Quetiapine—Myalgia—Doxorubicin—breast cancer	1.58e-05	7.35e-05	CcSEcCtD
Quetiapine—Anxiety—Doxorubicin—breast cancer	1.58e-05	7.32e-05	CcSEcCtD
Quetiapine—Paraesthesia—Methotrexate—breast cancer	1.57e-05	7.31e-05	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.57e-05	7.3e-05	CcSEcCtD
Quetiapine—Discomfort—Doxorubicin—breast cancer	1.56e-05	7.26e-05	CcSEcCtD
Quetiapine—Anorexia—Epirubicin—breast cancer	1.56e-05	7.26e-05	CcSEcCtD
Quetiapine—Dyspnoea—Methotrexate—breast cancer	1.56e-05	7.25e-05	CcSEcCtD
Quetiapine—Somnolence—Methotrexate—breast cancer	1.56e-05	7.23e-05	CcSEcCtD
Quetiapine—Dizziness—Capecitabine—breast cancer	1.55e-05	7.23e-05	CcSEcCtD
Quetiapine—Dry mouth—Doxorubicin—breast cancer	1.55e-05	7.19e-05	CcSEcCtD
Quetiapine—Vomiting—Docetaxel—breast cancer	1.54e-05	7.18e-05	CcSEcCtD
Quetiapine—Dyspepsia—Methotrexate—breast cancer	1.54e-05	7.16e-05	CcSEcCtD
Quetiapine—Rash—Docetaxel—breast cancer	1.53e-05	7.12e-05	CcSEcCtD
Quetiapine—Hypotension—Epirubicin—breast cancer	1.53e-05	7.11e-05	CcSEcCtD
Quetiapine—Dermatitis—Docetaxel—breast cancer	1.53e-05	7.11e-05	CcSEcCtD
Quetiapine—Confusional state—Doxorubicin—breast cancer	1.53e-05	7.1e-05	CcSEcCtD
Quetiapine—Decreased appetite—Methotrexate—breast cancer	1.52e-05	7.07e-05	CcSEcCtD
Quetiapine—Headache—Docetaxel—breast cancer	1.52e-05	7.07e-05	CcSEcCtD
Quetiapine—Anaphylactic shock—Doxorubicin—breast cancer	1.52e-05	7.04e-05	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Methotrexate—breast cancer	1.51e-05	7.02e-05	CcSEcCtD
Quetiapine—Fatigue—Methotrexate—breast cancer	1.51e-05	7.01e-05	CcSEcCtD
Quetiapine—Infection—Doxorubicin—breast cancer	1.51e-05	7e-05	CcSEcCtD
Quetiapine—Pain—Methotrexate—breast cancer	1.5e-05	6.96e-05	CcSEcCtD
Quetiapine—Vomiting—Capecitabine—breast cancer	1.49e-05	6.95e-05	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Epirubicin—breast cancer	1.49e-05	6.94e-05	CcSEcCtD
Quetiapine—Shock—Doxorubicin—breast cancer	1.49e-05	6.93e-05	CcSEcCtD
Quetiapine—Nervous system disorder—Doxorubicin—breast cancer	1.49e-05	6.91e-05	CcSEcCtD
Quetiapine—Thrombocytopenia—Doxorubicin—breast cancer	1.48e-05	6.9e-05	CcSEcCtD
Quetiapine—Rash—Capecitabine—breast cancer	1.48e-05	6.89e-05	CcSEcCtD
Quetiapine—Insomnia—Epirubicin—breast cancer	1.48e-05	6.89e-05	CcSEcCtD
Quetiapine—Dermatitis—Capecitabine—breast cancer	1.48e-05	6.88e-05	CcSEcCtD
Quetiapine—Tachycardia—Doxorubicin—breast cancer	1.48e-05	6.88e-05	CcSEcCtD
Quetiapine—Headache—Capecitabine—breast cancer	1.47e-05	6.85e-05	CcSEcCtD
Quetiapine—Skin disorder—Doxorubicin—breast cancer	1.47e-05	6.84e-05	CcSEcCtD
Quetiapine—Paraesthesia—Epirubicin—breast cancer	1.47e-05	6.84e-05	CcSEcCtD
Quetiapine—Hyperhidrosis—Doxorubicin—breast cancer	1.46e-05	6.81e-05	CcSEcCtD
Quetiapine—Dyspnoea—Epirubicin—breast cancer	1.46e-05	6.79e-05	CcSEcCtD
Quetiapine—Somnolence—Epirubicin—breast cancer	1.46e-05	6.77e-05	CcSEcCtD
Quetiapine—Anorexia—Doxorubicin—breast cancer	1.44e-05	6.72e-05	CcSEcCtD
Quetiapine—Nausea—Docetaxel—breast cancer	1.44e-05	6.7e-05	CcSEcCtD
Quetiapine—Feeling abnormal—Methotrexate—breast cancer	1.44e-05	6.7e-05	CcSEcCtD
Quetiapine—Dyspepsia—Epirubicin—breast cancer	1.44e-05	6.7e-05	CcSEcCtD
Quetiapine—Gastrointestinal pain—Methotrexate—breast cancer	1.43e-05	6.65e-05	CcSEcCtD
Quetiapine—Decreased appetite—Epirubicin—breast cancer	1.42e-05	6.62e-05	CcSEcCtD
Quetiapine—Hypotension—Doxorubicin—breast cancer	1.42e-05	6.58e-05	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Epirubicin—breast cancer	1.41e-05	6.57e-05	CcSEcCtD
Quetiapine—Fatigue—Epirubicin—breast cancer	1.41e-05	6.56e-05	CcSEcCtD
Quetiapine—Constipation—Epirubicin—breast cancer	1.4e-05	6.51e-05	CcSEcCtD
Quetiapine—Pain—Epirubicin—breast cancer	1.4e-05	6.51e-05	CcSEcCtD
Quetiapine—Nausea—Capecitabine—breast cancer	1.4e-05	6.49e-05	CcSEcCtD
Quetiapine—Abdominal pain—Methotrexate—breast cancer	1.38e-05	6.43e-05	CcSEcCtD
Quetiapine—Body temperature increased—Methotrexate—breast cancer	1.38e-05	6.43e-05	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.38e-05	6.42e-05	CcSEcCtD
Quetiapine—Insomnia—Doxorubicin—breast cancer	1.37e-05	6.37e-05	CcSEcCtD
Quetiapine—Paraesthesia—Doxorubicin—breast cancer	1.36e-05	6.33e-05	CcSEcCtD
Quetiapine—Dyspnoea—Doxorubicin—breast cancer	1.35e-05	6.28e-05	CcSEcCtD
Quetiapine—Feeling abnormal—Epirubicin—breast cancer	1.35e-05	6.27e-05	CcSEcCtD
Quetiapine—Somnolence—Doxorubicin—breast cancer	1.35e-05	6.26e-05	CcSEcCtD
Quetiapine—Gastrointestinal pain—Epirubicin—breast cancer	1.34e-05	6.23e-05	CcSEcCtD
Quetiapine—Dyspepsia—Doxorubicin—breast cancer	1.33e-05	6.2e-05	CcSEcCtD
Quetiapine—Decreased appetite—Doxorubicin—breast cancer	1.32e-05	6.12e-05	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Doxorubicin—breast cancer	1.31e-05	6.08e-05	CcSEcCtD
Quetiapine—Fatigue—Doxorubicin—breast cancer	1.31e-05	6.07e-05	CcSEcCtD
Quetiapine—Constipation—Doxorubicin—breast cancer	1.3e-05	6.02e-05	CcSEcCtD
Quetiapine—Pain—Doxorubicin—breast cancer	1.3e-05	6.02e-05	CcSEcCtD
Quetiapine—Abdominal pain—Epirubicin—breast cancer	1.29e-05	6.02e-05	CcSEcCtD
Quetiapine—Body temperature increased—Epirubicin—breast cancer	1.29e-05	6.02e-05	CcSEcCtD
Quetiapine—Hypersensitivity—Methotrexate—breast cancer	1.29e-05	5.99e-05	CcSEcCtD
Quetiapine—Asthenia—Methotrexate—breast cancer	1.26e-05	5.84e-05	CcSEcCtD
Quetiapine—Feeling abnormal—Doxorubicin—breast cancer	1.25e-05	5.81e-05	CcSEcCtD
Quetiapine—Gastrointestinal pain—Doxorubicin—breast cancer	1.24e-05	5.76e-05	CcSEcCtD
Quetiapine—Pruritus—Methotrexate—breast cancer	1.24e-05	5.76e-05	CcSEcCtD
Quetiapine—Hypersensitivity—Epirubicin—breast cancer	1.21e-05	5.61e-05	CcSEcCtD
Quetiapine—Abdominal pain—Doxorubicin—breast cancer	1.2e-05	5.57e-05	CcSEcCtD
Quetiapine—Body temperature increased—Doxorubicin—breast cancer	1.2e-05	5.57e-05	CcSEcCtD
Quetiapine—Diarrhoea—Methotrexate—breast cancer	1.2e-05	5.57e-05	CcSEcCtD
Quetiapine—Asthenia—Epirubicin—breast cancer	1.18e-05	5.46e-05	CcSEcCtD
Quetiapine—Pruritus—Epirubicin—breast cancer	1.16e-05	5.39e-05	CcSEcCtD
Quetiapine—Dizziness—Methotrexate—breast cancer	1.16e-05	5.38e-05	CcSEcCtD
Quetiapine—Diarrhoea—Epirubicin—breast cancer	1.12e-05	5.21e-05	CcSEcCtD
Quetiapine—Hypersensitivity—Doxorubicin—breast cancer	1.12e-05	5.19e-05	CcSEcCtD
Quetiapine—Vomiting—Methotrexate—breast cancer	1.11e-05	5.17e-05	CcSEcCtD
Quetiapine—Rash—Methotrexate—breast cancer	1.1e-05	5.13e-05	CcSEcCtD
Quetiapine—Dermatitis—Methotrexate—breast cancer	1.1e-05	5.13e-05	CcSEcCtD
Quetiapine—Headache—Methotrexate—breast cancer	1.1e-05	5.1e-05	CcSEcCtD
Quetiapine—Asthenia—Doxorubicin—breast cancer	1.09e-05	5.05e-05	CcSEcCtD
Quetiapine—Dizziness—Epirubicin—breast cancer	1.08e-05	5.03e-05	CcSEcCtD
Quetiapine—Pruritus—Doxorubicin—breast cancer	1.07e-05	4.98e-05	CcSEcCtD
Quetiapine—Vomiting—Epirubicin—breast cancer	1.04e-05	4.84e-05	CcSEcCtD
Quetiapine—Nausea—Methotrexate—breast cancer	1.04e-05	4.83e-05	CcSEcCtD
Quetiapine—Diarrhoea—Doxorubicin—breast cancer	1.04e-05	4.82e-05	CcSEcCtD
Quetiapine—Rash—Epirubicin—breast cancer	1.03e-05	4.8e-05	CcSEcCtD
Quetiapine—Dermatitis—Epirubicin—breast cancer	1.03e-05	4.8e-05	CcSEcCtD
Quetiapine—Headache—Epirubicin—breast cancer	1.03e-05	4.77e-05	CcSEcCtD
Quetiapine—Dizziness—Doxorubicin—breast cancer	1e-05	4.66e-05	CcSEcCtD
Quetiapine—Nausea—Epirubicin—breast cancer	9.73e-06	4.52e-05	CcSEcCtD
Quetiapine—Vomiting—Doxorubicin—breast cancer	9.63e-06	4.48e-05	CcSEcCtD
Quetiapine—Rash—Doxorubicin—breast cancer	9.55e-06	4.44e-05	CcSEcCtD
Quetiapine—Dermatitis—Doxorubicin—breast cancer	9.55e-06	4.44e-05	CcSEcCtD
Quetiapine—Headache—Doxorubicin—breast cancer	9.49e-06	4.41e-05	CcSEcCtD
Quetiapine—Nausea—Doxorubicin—breast cancer	9e-06	4.18e-05	CcSEcCtD
Quetiapine—HTR7—Signaling Pathways—IL6—breast cancer	1.02e-06	9.07e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—AKT1—breast cancer	1.02e-06	9.07e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—EGFR—breast cancer	1.02e-06	9.06e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—AKT1—breast cancer	1.02e-06	9.05e-06	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—PIK3CA—breast cancer	1.02e-06	9.04e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MAPK8—breast cancer	1.02e-06	9.04e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ABCB1—breast cancer	1.02e-06	9.03e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—AKT1—breast cancer	1.02e-06	9.02e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MAPK8—breast cancer	1.02e-06	9.01e-06	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—IL6—breast cancer	1.02e-06	9.01e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CASP3—breast cancer	1.02e-06	9e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—AKT1—breast cancer	1.01e-06	8.99e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL2—breast cancer	1.01e-06	8.99e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—NOS3—breast cancer	1.01e-06	8.98e-06	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TP53—breast cancer	1.01e-06	8.96e-06	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—HRAS—breast cancer	1.01e-06	8.95e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—IL6—breast cancer	1.01e-06	8.94e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MYC—breast cancer	1.01e-06	8.94e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MAPK8—breast cancer	1.01e-06	8.93e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TGFB1—breast cancer	1.01e-06	8.92e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—AKT1—breast cancer	1e-06	8.9e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MAPK8—breast cancer	1e-06	8.9e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MAPK3—breast cancer	1e-06	8.89e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MYC—breast cancer	1e-06	8.89e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—AKT1—breast cancer	1e-06	8.88e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TGFB1—breast cancer	1e-06	8.87e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—TYMS—breast cancer	1e-06	8.86e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—PIK3CA—breast cancer	9.96e-07	8.83e-06	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—IL6—breast cancer	9.96e-07	8.82e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—PIK3CA—breast cancer	9.91e-07	8.78e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—NOS3—breast cancer	9.9e-07	8.77e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PLA2G4A—breast cancer	9.89e-07	8.76e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GSTM1—breast cancer	9.89e-07	8.76e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—NCOR1—breast cancer	9.89e-07	8.76e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CCND1—breast cancer	9.89e-07	8.76e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—SRC—breast cancer	9.89e-07	8.76e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MAPK3—breast cancer	9.88e-07	8.75e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CD—breast cancer	9.88e-07	8.75e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—EGFR—breast cancer	9.87e-07	8.74e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—JUN—breast cancer	9.87e-07	8.74e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—PIK3CA—breast cancer	9.83e-07	8.71e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—PIK3CA—breast cancer	9.83e-07	8.71e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—EGFR—breast cancer	9.82e-07	8.7e-06	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—IL6—breast cancer	9.8e-07	8.68e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	9.79e-07	8.68e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MYC—breast cancer	9.77e-07	8.65e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—ALB—breast cancer	9.75e-07	8.64e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TGFB1—breast cancer	9.74e-07	8.63e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—SRC—breast cancer	9.73e-07	8.62e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—SRC—breast cancer	9.71e-07	8.6e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—SRC—breast cancer	9.68e-07	8.57e-06	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—HRAS—breast cancer	9.67e-07	8.57e-06	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—IL6—breast cancer	9.67e-07	8.56e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—KRAS—breast cancer	9.66e-07	8.56e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—SRC—breast cancer	9.65e-07	8.55e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TP53—breast cancer	9.64e-07	8.54e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—VEGFA—breast cancer	9.63e-07	8.53e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MYC—breast cancer	9.61e-07	8.51e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MMP9—breast cancer	9.6e-07	8.51e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TGFB1—breast cancer	9.59e-07	8.49e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	9.57e-07	8.47e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—SRC—breast cancer	9.55e-07	8.46e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—EGFR—breast cancer	9.55e-07	8.46e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PTEN—breast cancer	9.54e-07	8.46e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—STAT3—breast cancer	9.54e-07	8.45e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—SRC—breast cancer	9.53e-07	8.44e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TP53—breast cancer	9.51e-07	8.42e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TP53—breast cancer	9.51e-07	8.42e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—VEGFA—breast cancer	9.48e-07	8.39e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GPX1—breast cancer	9.47e-07	8.39e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—VEGFA—breast cancer	9.46e-07	8.38e-06	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—AKT1—breast cancer	9.45e-07	8.38e-06	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—AKT1—breast cancer	9.44e-07	8.37e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—VEGFA—breast cancer	9.43e-07	8.35e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—EGFR—breast cancer	9.4e-07	8.33e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—VEGFA—breast cancer	9.4e-07	8.32e-06	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—AKT1—breast cancer	9.38e-07	8.31e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—STAT3—breast cancer	9.38e-07	8.31e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CYP1A1—breast cancer	9.38e-07	8.31e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—STAT3—breast cancer	9.36e-07	8.29e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PIK3CB—breast cancer	9.36e-07	8.29e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MAPK8—breast cancer	9.34e-07	8.27e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—STAT3—breast cancer	9.33e-07	8.27e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—NOS3—breast cancer	9.33e-07	8.26e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—KRAS—breast cancer	9.32e-07	8.26e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—AKT1—breast cancer	9.31e-07	8.25e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—VEGFA—breast cancer	9.3e-07	8.24e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—STAT3—breast cancer	9.3e-07	8.24e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ERCC2—breast cancer	9.3e-07	8.24e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	9.28e-07	8.22e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—KRAS—breast cancer	9.28e-07	8.22e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTGS2—breast cancer	9.27e-07	8.21e-06	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—IL6—breast cancer	9.26e-07	8.2e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—HRAS—breast cancer	9.22e-07	8.17e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—STAT3—breast cancer	9.21e-07	8.16e-06	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—AKT1—breast cancer	9.19e-07	8.14e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—STAT3—breast cancer	9.19e-07	8.14e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3CB—breast cancer	9.13e-07	8.09e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MAPK3—breast cancer	9.11e-07	8.07e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—HRAS—breast cancer	9.09e-07	8.06e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—HRAS—breast cancer	9.09e-07	8.06e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTGS2—breast cancer	9.05e-07	8.02e-06	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—AKT1—breast cancer	9.04e-07	8.01e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—KRAS—breast cancer	9.02e-07	7.99e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MAPK3—breast cancer	8.96e-07	7.94e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MAPK3—breast cancer	8.94e-07	7.92e-06	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—AKT1—breast cancer	8.92e-07	7.9e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MAPK3—breast cancer	8.92e-07	7.9e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MAPK3—breast cancer	8.89e-07	7.87e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—KRAS—breast cancer	8.88e-07	7.87e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—PIK3CA—breast cancer	8.87e-07	7.86e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MYC—breast cancer	8.86e-07	7.85e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—SRC—breast cancer	8.85e-07	7.84e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TGFB1—breast cancer	8.84e-07	7.83e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—IL6—breast cancer	8.82e-07	7.82e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MAPK3—breast cancer	8.8e-07	7.8e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	8.78e-07	7.78e-06	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PIK3CA—breast cancer	8.78e-07	7.77e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—MTHFR—breast cancer	8.74e-07	7.74e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MYC—breast cancer	8.72e-07	7.72e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—IL6—breast cancer	8.7e-07	7.71e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—IL6—breast cancer	8.7e-07	7.71e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MYC—breast cancer	8.7e-07	7.71e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TGFB1—breast cancer	8.7e-07	7.7e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TGFB1—breast cancer	8.68e-07	7.69e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MYC—breast cancer	8.67e-07	7.68e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EGFR—breast cancer	8.67e-07	7.68e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TGFB1—breast cancer	8.65e-07	7.66e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MYC—breast cancer	8.64e-07	7.66e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TGFB1—breast cancer	8.62e-07	7.64e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—VEGFA—breast cancer	8.62e-07	7.64e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CB—breast cancer	8.61e-07	7.63e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TP53—breast cancer	8.59e-07	7.61e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—PIK3CA—breast cancer	8.57e-07	7.59e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MYC—breast cancer	8.56e-07	7.58e-06	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—AKT1—breast cancer	8.54e-07	7.57e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TGFB1—breast cancer	8.54e-07	7.57e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MYC—breast cancer	8.54e-07	7.56e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—STAT3—breast cancer	8.54e-07	7.56e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTGS2—breast cancer	8.53e-07	7.56e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EGFR—breast cancer	8.53e-07	7.55e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—PIK3CA—breast cancer	8.52e-07	7.55e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	8.52e-07	7.54e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EGFR—breast cancer	8.51e-07	7.54e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EGFR—breast cancer	8.48e-07	7.51e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EGFR—breast cancer	8.45e-07	7.49e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EGFR—breast cancer	8.37e-07	7.42e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EGFR—breast cancer	8.35e-07	7.4e-06	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—AKT1—breast cancer	8.34e-07	7.39e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—PIK3CA—breast cancer	8.29e-07	7.34e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TP53—breast cancer	8.29e-07	7.34e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TP53—breast cancer	8.25e-07	7.3e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—HRAS—breast cancer	8.21e-07	7.27e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—KRAS—breast cancer	8.19e-07	7.25e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	8.16e-07	7.23e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MAPK3—breast cancer	8.16e-07	7.22e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—AKT1—breast cancer	8.14e-07	7.21e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—AKT1—breast cancer	8.1e-07	7.17e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTEN—breast cancer	8.09e-07	7.16e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CAV1—breast cancer	8.06e-07	7.14e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—KRAS—breast cancer	8.06e-07	7.14e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PIK3CA—breast cancer	8.05e-07	7.13e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—KRAS—breast cancer	8.04e-07	7.12e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—AKT1—breast cancer	8.03e-07	7.11e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—AKT1—breast cancer	8.03e-07	7.11e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TP53—breast cancer	8.02e-07	7.1e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—KRAS—breast cancer	8.01e-07	7.1e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—KRAS—breast cancer	7.99e-07	7.08e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MYC—breast cancer	7.93e-07	7.03e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—HRAS—breast cancer	7.93e-07	7.02e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TGFB1—breast cancer	7.91e-07	7.01e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—KRAS—breast cancer	7.91e-07	7.01e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTEN—breast cancer	7.89e-07	6.99e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TP53—breast cancer	7.89e-07	6.99e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—KRAS—breast cancer	7.89e-07	6.99e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—HRAS—breast cancer	7.89e-07	6.99e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—IL6—breast cancer	7.86e-07	6.96e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EGFR—breast cancer	7.76e-07	6.87e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—HRAS—breast cancer	7.67e-07	6.79e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—IL6—breast cancer	7.59e-07	6.72e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—HRAS—breast cancer	7.55e-07	6.69e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—IL6—breast cancer	7.55e-07	6.69e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—PIK3CA—breast cancer	7.52e-07	6.66e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTEN—breast cancer	7.44e-07	6.59e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—PIK3CA—breast cancer	7.4e-07	6.56e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—PIK3CA—breast cancer	7.39e-07	6.54e-06	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PIK3CA—breast cancer	7.38e-07	6.54e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—PIK3CA—breast cancer	7.36e-07	6.52e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CG—breast cancer	7.34e-07	6.51e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—IL6—breast cancer	7.34e-07	6.5e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—PIK3CA—breast cancer	7.34e-07	6.5e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—KRAS—breast cancer	7.33e-07	6.49e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TP53—breast cancer	7.28e-07	6.45e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—PIK3CA—breast cancer	7.27e-07	6.44e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—AKT1—breast cancer	7.25e-07	6.42e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	7.25e-07	6.42e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—IL6—breast cancer	7.22e-07	6.4e-06	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—AKT1—breast cancer	7.17e-07	6.35e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TP53—breast cancer	7.16e-07	6.34e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TP53—breast cancer	7.14e-07	6.33e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TP53—breast cancer	7.12e-07	6.31e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TP53—breast cancer	7.1e-07	6.29e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TP53—breast cancer	7.03e-07	6.23e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TP53—breast cancer	7.01e-07	6.21e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—AKT1—breast cancer	7e-07	6.2e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—AKT1—breast cancer	6.96e-07	6.17e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—HRAS—breast cancer	6.96e-07	6.17e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—HRAS—breast cancer	6.85e-07	6.07e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—HRAS—breast cancer	6.83e-07	6.05e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—HRAS—breast cancer	6.81e-07	6.03e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—HRAS—breast cancer	6.79e-07	6.01e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—AKT1—breast cancer	6.77e-07	6e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	6.73e-07	5.97e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—HRAS—breast cancer	6.72e-07	5.96e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—HRAS—breast cancer	6.7e-07	5.94e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—AKT1—breast cancer	6.66e-07	5.9e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IL6—breast cancer	6.66e-07	5.9e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—AKT1—breast cancer	6.58e-07	5.83e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IL6—breast cancer	6.55e-07	5.81e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IL6—breast cancer	6.54e-07	5.79e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IL6—breast cancer	6.52e-07	5.77e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TP53—breast cancer	6.51e-07	5.77e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IL6—breast cancer	6.5e-07	5.76e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CD—breast cancer	6.46e-07	5.72e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IL6—breast cancer	6.43e-07	5.7e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IL6—breast cancer	6.42e-07	5.68e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ALB—breast cancer	6.37e-07	5.65e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—HRAS—breast cancer	6.23e-07	5.52e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—AKT1—breast cancer	6.14e-07	5.44e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—NOS3—breast cancer	6.1e-07	5.4e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—AKT1—breast cancer	6.05e-07	5.36e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—AKT1—breast cancer	6.03e-07	5.34e-06	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—AKT1—breast cancer	6.03e-07	5.34e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—AKT1—breast cancer	6.01e-07	5.33e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—AKT1—breast cancer	5.99e-07	5.31e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL6—breast cancer	5.96e-07	5.28e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—AKT1—breast cancer	5.94e-07	5.26e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—AKT1—breast cancer	5.92e-07	5.24e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PIK3CA—breast cancer	5.71e-07	5.05e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CB—breast cancer	5.63e-07	4.99e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTGS2—breast cancer	5.58e-07	4.94e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3CA—breast cancer	5.57e-07	4.93e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—AKT1—breast cancer	5.5e-07	4.87e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CA—breast cancer	5.25e-07	4.65e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTEN—breast cancer	4.86e-07	4.31e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—AKT1—breast cancer	4.66e-07	4.13e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—AKT1—breast cancer	4.55e-07	4.03e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—AKT1—breast cancer	4.29e-07	3.8e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CA—breast cancer	3.43e-07	3.04e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—AKT1—breast cancer	2.8e-07	2.48e-06	CbGpPWpGaD
